Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NeuroMetrix Q2 EPS $(0.74) Up From $(1.52) YoY, Sales $769,148 Down From $1.65M YoY

Author: Benzinga Newsdesk | August 06, 2024 07:09am
NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(0.74) per share. This is a 51.32 percent increase over losses of $(1.52) per share from the same period last year. The company reported $769.00 in sales this quarter. This is a 99.95 percent decrease over sales of $1.65 million the same period last year.

Posted In: NURO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist